Viewing data from:

OGESTREL 0.5/50-21

ANDA

ETHINYL ESTRADIOL; NORGESTREL | A075406 | WATSON LABORATORIES INC

2 strengths0 unique patents0 unique exclusivities

Approval Letters

2 letters from Drugs@FDA

Date	Submission	Document
Apr 24, 2013	SUPPL -16	View Letter (PDF)
Dec 15, 1999	ORIG -1	View Letter (PDF)

Source: Drugs@FDA application documents.

Products (2)

Sort:

#001 — 0.05MG;0.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

0 patents0 exclusivities▴

TABLET;ORAL-21 | Approved: Dec 15, 1999

No patent or exclusivity listings for this strength.

#002 — 0.05MG;0.5MG

0 patents0 exclusivities▾

TABLET;ORAL-28 | Approved: Dec 15, 1999